US 12059443
Method for treating cancer using dengue virus serotype 1 (DENV-1)
granted A61KA61K35/76A61K9/0019
Quick answer
US patent 12059443 (Method for treating cancer using dengue virus serotype 1 (DENV-1)) held by PrimeVax Immuno-Oncology expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PrimeVax Immuno-Oncology
- Grant date
- Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/76, A61K9/0019, A61K9/08, A61K9/19